Pay in 4 interest-free payments of $5.47 Learn more
Ships within 48 hours · Estimated delivery Nov 7 - Nov 12
If the data is unfavorable to their own drugs, it will not only weaken their market competitiveness, but may even lead to the revocation of the indication by regulatory authorities, causing double blows to the pharmaceutical company in terms of economy and reputation
References: [1] Buy 5 and save 10% Buy 10 and save 15% Legal Notice Regarding This Product THIS PRODUCT IS STRICTLY INTENDED FOR RESEARCH USE ONLY
The list prices for these drugs average about $1,000 per month in U.S
Until then, Retatrutide remains in the experimental stage, and its dosage is still under investigation
US$ 22.59
US$ 25.14
US$ 25.78
